Abstract

Nitrogen doped-TiO2 thin film was deposited by plasma enhanced chemical vapour deposition (PECVD) process and its applicability as a drug-binding matrix was investigated in the preparation of drug eluting stents. N–TiO2 film was deposited at 5 W and uniformly covered metallic stent surfaces. Films showed excellent mechanical stability and good adhesion. Alpha lipoic acid, heparin, and abciximab could then be grafted onto the N–TiO2 film through ester bond formation after water plasma modification of the films' surfaces. Drug-grafted N–TiO2 films showed smooth surfaces and good blood compatibility in in vitro platelet adhesion tests. The films maintained uniform coverings, without peeling, even after expansion by a balloon catheter. Grafted-heparin and abciximab could be released continuously for three weeks from drug-grafted N–TiO2 stents in in vitro drug release test. Such immunosuppressive and antiproliferative drug-grafted N–TiO2 film is expected to minimize potential problems related to organic polymers and the risk of direct contact of a bare metal surface with a blood vessel. Hence, the N–TiO2 films prepared in this study are promising alternatives to organic polymers for the preparation of drug-eluting stents.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.